Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.64 SEK | -1.49% | 0.00% | -5.96% |
Sales 2024 * | 26.75M 2.45M | Sales 2025 * | 52.18M 4.78M | Capitalization | 300M 27.48M |
---|---|---|---|---|---|
Net income 2024 * | -96M -8.79M | Net income 2025 * | -93M -8.51M | EV / Sales 2024 * | 7.68 x |
Net cash position 2024 * | 94.7M 8.67M | Net cash position 2025 * | 58M 5.31M | EV / Sales 2025 * | 4.64 x |
P/E ratio 2024 * |
-2.96
x | P/E ratio 2025 * |
-2.12
x | Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.69% |
Latest transcript on Medivir AB
1 day | +0.37% | ||
1 week | +0.75% | ||
Current month | -1.73% | ||
1 month | -3.74% | ||
3 months | -3.54% | ||
6 months | -56.61% | ||
Current year | -5.26% |
Managers | Title | Age | Since |
---|---|---|---|
Jens Lindberg
CEO | Chief Executive Officer | 53 | 22-01-23 |
Director of Finance/CFO | 50 | 19-08-11 | |
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Director/Board Member | 68 | 18-05-02 | |
Yilmaz Mahshid
BRD | Director/Board Member | 45 | 20-05-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 2.68 | 0.00% | 106 426 |
24-04-18 | 2.68 | -0.74% | 85,646 |
24-04-17 | 2.7 | +1.50% | 102,364 |
24-04-16 | 2.66 | -1.48% | 154,996 |
24-04-15 | 2.7 | +0.75% | 764,348 |
Delayed Quote Nasdaq Stockholm, April 19, 2024 at 09:16 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.26% | 27.49M | |
-3.30% | 102B | |
+1.79% | 96.07B | |
-1.60% | 21.66B | |
-18.35% | 20.77B | |
-7.68% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |
- Stock Market
- Equities
- MVIR B Stock